Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	266.36	317.5	474.88	651.55	1,029	712.36
Short-Term Investments	710.68	591.22	658.47	696.8	366.3	871.2
Trading Asset Securities	-	-	18.66	17.77	19.65	20.71
Cash & Short-Term Investments	977.04	908.72	1,152	1,366	1,415	1,604
Cash Growth	11.94%	-21.12%	-15.67%	-3.43%	-11.82%	-1.48%
Accounts Receivable	230.48	175.16	138.92	130.52	149.05	102.34
Other Receivables	4.44	2.61	2.8	1.84	2.06	306.62
Receivables	234.92	177.77	141.71	132.36	151.11	408.97
Inventory	178.59	161.79	188.76	115.2	115.18	103.02
Prepaid Expenses	46.1	12.21	16.43	3.84	7.84	8.44
Other Current Assets	2.94	8.26	125.78	2.04	2.13	0.3
Total Current Assets	1,440	1,269	1,625	1,620	1,691	2,125
Property, Plant & Equipment	28.13	29.51	7.65	14.54	22.51	28.82
Long-Term Investments	348.72	418.6	119.7	134.74	93.33	77.48
Other Intangible Assets	0.45	0.6	0.79	0.05	0.25	2.91
Long-Term Accounts Receivable	13.51	17.1	-	1.99	6.68	11.25
Long-Term Deferred Tax Assets	9.66	10.41	7.77	6.71	10.07	8.76
Other Long-Term Assets	8.87	4.81	4.83	5.63	7.33	10.74
Total Assets	1,849	1,750	1,765	1,783	1,831	2,265
Accounts Payable	66.57	25.9	62.69	46.71	89.95	28.52
Accrued Expenses	65.06	81	96.88	80.1	95.23	51
Current Portion of Leases	10.05	9.81	5.05	10.08	9.83	9.39
Current Income Taxes Payable	18.16	56.41	80.35	40.51	40.15	121.39
Current Unearned Revenue	23.76	11.52	8.26	8.05	13.59	12.44
Other Current Liabilities	186.88	68.57	35.65	33.75	30.42	17.56
Total Current Liabilities	370.49	253.2	288.88	219.18	279.16	240.3
Long-Term Leases	29.39	36.96	-	5.6	15.68	24.59
Long-Term Deferred Tax Liabilities	-	3.3	0.98	28.18	-	-
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.26	1.49
Total Liabilities	401.14	294.71	291.12	254.22	296.1	266.37
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	241.8	241.8	331.89	421.99	512.08	692.27
Retained Earnings	755.51	762.78	691.96	548.78	479.09	778.38
Comprehensive Income & Other	-	-	-	107.77	93.31	77.45
Shareholders' Equity	1,448	1,455	1,474	1,529	1,535	1,999
Total Liabilities & Equity	1,849	1,750	1,765	1,783	1,831	2,265
Total Debt	39.44	46.77	5.05	15.68	25.5	33.98
Net Cash (Debt)	937.6	861.95	1,147	1,350	1,389	1,570
Net Cash Growth	13.83%	-24.85%	-15.07%	-2.78%	-11.54%	-0.94%
Net Cash Per Share	20.73	19.08	25.44	29.95	30.80	34.76
Filing Date Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Working Capital	1,069	1,016	1,336	1,400	1,412	1,885
Book Value Per Share	32.14	32.30	32.73	33.94	34.07	44.37
Tangible Book Value	1,447	1,454	1,474	1,529	1,535	1,996
Tangible Book Value Per Share	32.13	32.29	32.71	33.94	34.07	44.30
Machinery	-	-	-	-	-	1
Leasehold Improvements	-	-	-	-	-	20.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.